Korro Bio KRRO
NASDAQ KRRO
$9.51 -0.40 (-4.04%)
As of: Oct 1, 2026 · 10:30 AM EDT

Korro Bio (KRRO) Receivables - Other (2018 - 2020)

Updated

Korro Bio (KRRO) reported Receivables - Other of $246,000 for Q1 2020, down 69.4% from the prior quarter.

Analysis

Korro Bio (KRRO) Receivables - Other (2018 - 2020) Analysis & Trends

At the end of FY2019, Korro Bio posted Receivables - Other of $805,000, up 400.0% from FY2018.

  • By year, Receivables - Other came in at $161,000 in FY2018.
  • The Q1 2020 figure ranks as the lowest quarterly Receivables - Other since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Korro Bio 145.73 Mn -250.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 246,000.00
Dec 31, 2019 805,000.00
Sep 30, 2019 408,000.00
Dec 31, 2018 161,000.00
API Access

Korro Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=KRRO&period=max&api_key=YOUR_API_KEY